<DOC>
	<DOCNO>NCT00819728</DOCNO>
	<brief_summary>The main purpose study determine activity weekly combination docetaxel ( Taxotere ) irinotecan term response rate subject advance , previously untreated , non-small cell lung cancer . It also determine activity combination term response duration , time progression , median survival , overall survival , percent one-year survival , well side-effect toxicity profile weekly Taxotere weekly irinotecan .</brief_summary>
	<brief_title>Trial Weekly Taxotere Irinotecan ( CPT-11 ) Patients With Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Microscopically cytologically confirm nonsmall cell lung cancer . Histology may include large cell , squamous cell , undifferentiated , bronchioalveolar carcinoma , adenocarcinoma , small cell carcinoid . Inoperable stage III B metastatic stage IV NSCLC Measurable ( bidimensionally ) indicator lesion ( ) irradiate . No prior systemic chemotherapy . Prior irradiation NSCLC permit , however , measurable evaluable nonmeasurable disease must completely outside radiation portal must radiologic proof progressive disease . If patient receive palliative radiation , chest , one site 30 cGy less , patient eligible chemotherapy proceed immediately palliative RT . ECOG performance status 0 1 screening first day treatment Life expectancy = 12 week . Patients must &gt; 4 week prior radiation therapy pelvis , spine long bone , must recover side effect . Patients must &gt; 3 week prior major surgery , except simple biopsy placement venous access device . No patient may follow : Neutrophils &lt; 1,500/mm3 . Platelets &lt; 100,000/mm3 . Serum creatinine &gt; 1.8 mg/dL . SGOT &gt; 1.5 time upper limit normal institution . Total bilirubin &gt; upper limit normal institution . Alkaline phosphatase &gt; 5 time upper limit normal institution . Pregnant lactating female females childbearing potential employ adequate contraception . History malignancy within last five year could affect diagnosis NSCLC , except basal cell carcinoma skin carcinoma situ cervix . Current metastatic CNS disease , present , must treat clinically stable least 3 week prior initial Taxotere treatment . Patients document meningeal carcinomatosis eligible . Grade 2 great peripheral neuropathy . Psychological , familial , sociological geographical condition permit weekly medical followup compliance study protocol . Patients medically unstable , include limited active infection , acute hepatitis , gastrointestinal bleeding , uncontrolled cardiac arrhythmia , uncontrolled angina , uncontrolled hypercalcemia , uncompensated congestive heart failure , uncontrolled diabetes , dementia , seizure , superior vena cava syndrome , patient whose circumstance permit completion study require followup . Patients history hypersensitivity reaction product contain Polysorbate 80 ( Tween 80 ) . Patients require concurrent treatment corticosteroid unless chronic treatment ( &gt; 6 month ) low dos ( &lt; 20 mg/day methylprednisolone equivalent ) . Patients receive investigational drug within 3 week registration . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>